88 related articles for article (PubMed ID: 12844409)
1. [Down-regulation of expression of vascular endothelial growth factor induced by arsenic trioxide in bone marrow cells of chronic myeloid leukemia].
Li L; Zhang R; Zhu ZL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Jun; 11(3):263-5. PubMed ID: 12844409
[TBL] [Abstract][Full Text] [Related]
2. Clinical relevance of VEGF receptors 1 and 2 in patients with chronic myelogenous leukemia.
Verstovsek S; Lunin S; Kantarjian H; Manshouri T; Faderl S; Cortes J; Giles F; Albitar M
Leuk Res; 2003 Jul; 27(7):661-9. PubMed ID: 12681367
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of cellular vascular endothelial growth factor expression in chronic phase chronic myeloid leukemia.
Verstovsek S; Kantarjian H; Manshouri T; Cortes J; Giles FJ; Rogers A; Albitar M
Blood; 2002 Mar; 99(6):2265-7. PubMed ID: 11877311
[TBL] [Abstract][Full Text] [Related]
4. VEGF depletion enhances bcr-abl-specific sensitivity of arsenic trioxide in chronic myelogenous leukemia.
Luo X; Feng M; Zhu X; Li Y; Fei J; Zhang Y
Hematology; 2013 Nov; 18(6):334-40. PubMed ID: 24129092
[TBL] [Abstract][Full Text] [Related]
5. Imatinib mesylate (STI-571) reduces Bcr-Abl-mediated vascular endothelial growth factor secretion in chronic myelogenous leukemia.
Ebos JM; Tran J; Master Z; Dumont D; Melo JV; Buchdunger E; Kerbel RS
Mol Cancer Res; 2002 Dec; 1(2):89-95. PubMed ID: 12496355
[TBL] [Abstract][Full Text] [Related]
6. [Effects of ST1571 on the development of dendritic cells derived from bone marrow mononuclear cells in patients with chronic myeloid leukemia].
Zheng SE; Jin J; Tong XM; Qian WB; Xue YQ
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):920-3. PubMed ID: 17533744
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of hepatocyte growth factor and microvessel bone marrow density in patients with chronic myeloid leukaemia.
Zhelyazkova AG; Tonchev AB; Kolova P; Ivanova L; Gercheva L
Scand J Clin Lab Invest; 2008; 68(6):492-500. PubMed ID: 18609087
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis in fetal tendon development: spatial and temporal expression of the angiogenic peptide vascular endothelial cell growth factor.
Petersen W; Pufe T; Kurz B; Mentlein R; Tillmann B
Anat Embryol (Berl); 2002 Jul; 205(4):263-70. PubMed ID: 12136256
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of VEGF in the bone marrow of patients with chronic myeloid leukemia and correlation with the phase of disease.
Krauth MT; Simonitsch I; Aichberger KJ; Mayerhofer M; Sperr WR; Sillaber C; Schneeweiss B; Mann G; Gadner H; Valent P
Am J Clin Pathol; 2004 Apr; 121(4):473-81. PubMed ID: 15080298
[TBL] [Abstract][Full Text] [Related]
10. Role of the microenvironment in promoting angiogenesis in acute myeloid leukemia.
Litwin C; Leong KG; Zapf R; Sutherland H; Naiman SC; Karsan A
Am J Hematol; 2002 May; 70(1):22-30. PubMed ID: 11994978
[TBL] [Abstract][Full Text] [Related]
11. [Study on the role of angiogenesis and related factors in leukemias].
Zhang Y; Gu J; Wang M; Ma L; Wang XL; He B; Sun M
Zhonghua Xue Ye Xue Za Zhi; 2005 Mar; 26(3):175-8. PubMed ID: 15946533
[TBL] [Abstract][Full Text] [Related]
12. [Expression of vascular endothelial growth factor in bone marrow cells of patients with acute myeloid leukemia].
Xu D; Meng FY; Zhang Y
Di Yi Jun Yi Da Xue Xue Bao; 2002 Apr; 22(4):357-9. PubMed ID: 12422902
[TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide inhibits growth of human multiple myeloma cells in the bone marrow microenvironment.
Hayashi T; Hideshima T; Akiyama M; Richardson P; Schlossman RL; Chauhan D; Munshi NC; Waxman S; Anderson KC
Mol Cancer Ther; 2002 Aug; 1(10):851-60. PubMed ID: 12492118
[TBL] [Abstract][Full Text] [Related]
14. [Angiogenesis in different clinical phases of chronic myeloid leukemia].
Krasowska-Kwiecień A; Kijowski J; Łukasiewicz E; Sacha T; Foryciarz K; Majka M; Ratajczak MZ; Skotnicki AB
Przegl Lek; 2009; 66(9):471-8. PubMed ID: 21033405
[TBL] [Abstract][Full Text] [Related]
15. Arsenic Trioxide overcomes cell adhesion-mediated drug resistance through down-regulating the expression of beta(1)-integrin in K562 chronic myelogenous leukemia cell line.
Guo-Bao W; Xiao-Qin C; Qi-Rong G; Jie L; Gui-Nan L; Yue L
Leuk Lymphoma; 2010 Jun; 51(6):1090-7. PubMed ID: 20470221
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia. Correlation between VEGF expression and the FAB category.
Ghannadan M; Wimazal F; Simonitsch I; Sperr WR; Mayerhofer M; Sillaber C; Hauswirth AW; Gadner H; Chott A; Horny HP; Lechner K; Valent P
Am J Clin Pathol; 2003 May; 119(5):663-71. PubMed ID: 12760284
[TBL] [Abstract][Full Text] [Related]
17. [VEGF (vascular endothelial growth factor) concentration in serum and pleural fluid of patients with pleural malignancy and pleural tuberculosis].
Ziora D; Sielska-Spytek E; Dworniczak S; Oklek K; Kozielski J
Pneumonol Alergol Pol; 2002; 70(9-10):458-67. PubMed ID: 12710098
[TBL] [Abstract][Full Text] [Related]
18. [Expression of Vascular Endothelial Growth Factor in the Bone Marrow Cells from Adult Chronic Myelogenous Leukemia].
Ruan GR; Liu YR; Chen SS; Li JL; Qin YZ; Fu JY; Bai RK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2001 Mar; 9(1):5-9. PubMed ID: 12578635
[TBL] [Abstract][Full Text] [Related]
19. EGFR antisense treatment of human HNSCC cell lines down-regulates VEGF expression and endothelial cell migration.
Riedel F; Götte K; Li M; Hörmann K; Grandis JR
Int J Oncol; 2002 Jul; 21(1):11-6. PubMed ID: 12063543
[TBL] [Abstract][Full Text] [Related]
20. AID expression is correlated with Bcr-Abl expression in CML-LBC and can be down-regulated by As2O3 and/or imatinib.
Liu Z; Wu X; Duan Y; Wang Y; Shan B; Kong J; Ma X; Bao Y
Leuk Res; 2011 Oct; 35(10):1355-9. PubMed ID: 21570118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
